EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Continuous hemicrania responsive to early testing with indomethacin: case report

Matheus Miller Cavalcante Carvalho Lacerda, Lays Sthefany Siqueira Costa, Caio César Leite Martins, Brícia Maia Leite Dantas, Erik de Oliveira Tavares, Arthur do Nascimento Teodósio, Rafael Carvalheira Vieira Silva

Headache Medicine · 12.05.2026 · 17 (2) · 94-97

DOI: 10.48208/headachemed.2026.12 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Headache Medicine, online erschienen am 12.05.2026. Verfasst von Matheus Miller Cavalcante Carvalho Lacerda und 6 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IntroductionHemicrania continua (HC) is a primary headache characterized by persistent unilateral pain of moderate intensity, associated with autonomic signs and responsive to indomethacin. Early diagnosis is important because it is a highly disabling condition, and appropriate and immediate treatment can lead to symptom remission.Case ReportA 63-year-old woman presented with a 5-day history of intense and continuous left temporal headache without remission, associated with conjunctival hyperemia, tearing, and semiptosis. Pain intensity was rated 9/10, with no response to common analgesics. Neurological examination confirmed ipsilateral autonomic signs, without other focal deficits. Brain MRI with contrast showed no abnormalities. Although she did not meet the minimum duration criterion for HC, early treatment with indomethacin (50 mg twice daily) was initiated, resulting in significant clinical improvement within six days, with remission of pain and autonomic signs. DiscussionThe diagnosis of hemicrania continua is based on continuous unilateral headache, presence of ipsilateral autonomic symptoms, and complete response to indomethacin. However, many patients may not meet the duration criterion at initial presentation. ConclusionEarly therapeutic evaluation with indomethacin should be considered in patients presenting with continuous unilateral headache and autonomic symptoms suggestive of hemicrania continua, even when the minimum duration criterion has not yet been reached. Early diagnosis may significantly reduce disease impact and improve clinical outcomes.

Zitieren

APA

Lacerda, M. M. C. C., Costa, L. S. S., Martins, C. C. L., Dantas, B. M. L., Tavares, E. D. O., Teodósio, A. D. N., & Silva, R. C. V. (2026). Continuous hemicrania responsive to early testing with indomethacin: case report. Headache Medicine, 17(2), 94-97. https://doi.org/10.48208/headachemed.2026.12

Vancouver

Lacerda MMCC, Costa LSS, Martins CCL, Dantas BML, Tavares EDO, Teodósio ADN, et al. Continuous hemicrania responsive to early testing with indomethacin: case report. Headache Medicine. 2026;17(2):94-97. doi:10.48208/headachemed.2026.12

BibTeX
@article{Lacerda2026,
  author = {Lacerda, Matheus Miller Cavalcante Carvalho and Costa, Lays Sthefany Siqueira and Martins, Caio César Leite and Dantas, Brícia Maia Leite and Tavares, Erik de Oliveira and Teodósio, Arthur do Nascimento and Silva, Rafael Carvalheira Vieira},
  title = {Continuous hemicrania responsive to early testing with indomethacin: case report},
  journal = {Headache Medicine},
  year = {2026},
  volume = {17},
  number = {2},
  pages = {94--97},
  doi = {10.48208/headachemed.2026.12}
}
Kostenlos starten →